FDA Approved: ACZONE — Supplemental Application (Almirall, LLC)

View source ↗

Summary

FDA approved a supplemental application for ACZONE (dapsone) submitted by Almirall, LLC. The approval updates the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• ACZONE (DAPSONE)

Snippet

SUPPL AP for ACZONE (DAPSONE)